top of page
Nelson Advisors >
European Healthcare Technology Investment Banking
!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
Homepage
Meet Nelson Advisors
Email Nelson Advisors
HealthTech M&A Multiples August 2026: Current Trends and Variables Driving Valuations
The Frozen Digital Health IPO Window and the HealthTech Founder's Real Exit Map in 2026
The AI Deflation Wave: Platform versus Wrapper Valuation Dynamics in Healthcare AI
Cross Border Exits for HealthTech, Health AI, MedTech, Digital Health Founders: Why Your Most Likely Buyer Isn't in Your Country
The €25M to €250M Sweet Spot: Why Europe's HealthTech Mid-Market Is Where Private Equity Returns Are Being Made in 2026
Buy and Build in European HealthTech: A Playbook for Platform Selection, Bolt-On Sequencing and Multiple Arbitrage
Five Emerging HealthTech Sub Sectors Private Equity Should Be Screening Now Before the Multiples Move
The Strategic Transformation of Community Pharmacy within the NHS Neighbourhood Health Model
Geographic Arbitrage in European HealthTech: Why the Next Platform Deal Might Be in the Nordics, DACH or the Netherlands, Not London
Capitalising on HealthTech Regulation: Analysis of Thoma Bravo’s Acquisition of padoa
Abbott’s Mission Led Artificial Intelligence Strategy
This Week in European HealthTech, MedTech and Health AI: 31st July 2026
Deconstructing the Smart Ring Landscape: A Technical and Strategic Evaluation of the Leep Ring Versus the Oura Ecosystem
The Evolutionary Blueprint of Healthcare Artificial Intelligence: 10 Key Milestones
Comparative Analysis of European Healthcare Technology Frameworks: Assessment, Reimbursement and Systemic Integration Pathways
Strategic Expansion and Technological Evolution in AI-Powered Cardiothoracic Clinical Research: An Analysis of Qureight’s $20 Million Series B Financing
Nelson Advisors LLP
About Healthcare.Digital
bottom of page
